Connection

Ciro Indolfi to Risk Factors

Back to Details
This is a "connection" page, showing publications Ciro Indolfi has written about Risk Factors.
Ciro Indolfi
Connection Strength
0.133
Risk Factors
  1. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS One. 2020; 15(8):e0237131.
    View in: PubMed
    Score: 0.027
  2. Non-coding RNAs in vascular remodeling and restenosis. Vascul Pharmacol. 2019 03; 114:49-63.
    View in: PubMed
    Score: 0.024
  3. Should we rethink the indications for implantable cardioverter-defibrillators in non-ischaemic dilated cardiomyopathy? Eur J Heart Fail. 2018 03; 20(3):417-419.
    View in: PubMed
    Score: 0.022
  4. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis. BMC Cardiovasc Disord. 2017 09 06; 17(1):240.
    View in: PubMed
    Score: 0.022
  5. Transcatheter aortic valve implantation in patients at intermediate surgical risk. Int J Cardiol. 2017 Sep 15; 243:161-168.
    View in: PubMed
    Score: 0.021
  6. Antithrombotic Treatment after Transcatheter Heart Valves Implant. Semin Thromb Hemost. 2018 Feb; 44(1):38-45.
    View in: PubMed
    Score: 0.006
  7. Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds. JACC Cardiovasc Interv. 2017 09 25; 10(18):1819-1827.
    View in: PubMed
    Score: 0.006
  8. Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs. BMC Cardiovasc Disord. 2017 06 07; 17(1):147.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.